Figure 6
Figure 6. Enhanced depletion of lymphoma and myeloma cells from whole blood. Fresh heparinized human blood was mixed with Daudi or CAG cells and incubated with 1nM of C2-2b-2b, 734-2b-2b, hL243γ4p, or hL243γ4p+734-2b for 48 hours. The number of CAG, Daudi, B, T, monocyte, and dendritic (mDC-1, mDC-2, and pDC) cells in treated blood samples was plotted as a percentage of the number of the specific cell type counted in untreated blood by flow cytometry. Error bars indicate SDs. *Daudi cells were not tested with hL243γ4p+734-2b.

Enhanced depletion of lymphoma and myeloma cells from whole blood. Fresh heparinized human blood was mixed with Daudi or CAG cells and incubated with 1nM of C2-2b-2b, 734-2b-2b, hL243γ4p, or hL243γ4p+734-2b for 48 hours. The number of CAG, Daudi, B, T, monocyte, and dendritic (mDC-1, mDC-2, and pDC) cells in treated blood samples was plotted as a percentage of the number of the specific cell type counted in untreated blood by flow cytometry. Error bars indicate SDs. *Daudi cells were not tested with hL243γ4p+734-2b.

Close Modal

or Create an Account

Close Modal
Close Modal